Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response

2006 ◽  
Vol 35 (4-5) ◽  
pp. 202-209 ◽  
Author(s):  
Jean D. Boyer ◽  
Sanjeev Kumar ◽  
Tara Robinson ◽  
Rose Parkinson ◽  
Ling Wu ◽  
...  
2021 ◽  
Vol 17 (12) ◽  
pp. e1009735
Author(s):  
Melanie E. Moses ◽  
Steven Hofmeyr ◽  
Judy L. Cannon ◽  
Akil Andrews ◽  
Rebekah Gridley ◽  
...  

A key question in SARS-CoV-2 infection is why viral loads and patient outcomes vary dramatically across individuals. Because spatial-temporal dynamics of viral spread and immune response are challenging to study in vivo, we developed Spatial Immune Model of Coronavirus (SIMCoV), a scalable computational model that simulates hundreds of millions of lung cells, including respiratory epithelial cells and T cells. SIMCoV replicates viral growth dynamics observed in patients and shows how spatially dispersed infections can lead to increased viral loads. The model also shows how the timing and strength of the T cell response can affect viral persistence, oscillations, and control. By incorporating spatial interactions, SIMCoV provides a parsimonious explanation for the dramatically different viral load trajectories among patients by varying only the number of initial sites of infection and the magnitude and timing of the T cell immune response. When the branching airway structure of the lung is explicitly represented, we find that virus spreads faster than in a 2D layer of epithelial cells, but much more slowly than in an undifferentiated 3D grid or in a well-mixed differential equation model. These results illustrate how realistic, spatially explicit computational models can improve understanding of within-host dynamics of SARS-CoV-2 infection.


Nature Cancer ◽  
2021 ◽  
Author(s):  
Laura Poillet-Perez ◽  
Daniel W. Sharp ◽  
Yang Yang ◽  
Saurabh V. Laddha ◽  
Maria Ibrahim ◽  
...  

2013 ◽  
Vol 190 (12) ◽  
pp. 6145-6154 ◽  
Author(s):  
Zhubo Chen ◽  
Yanmei Han ◽  
Yan Gu ◽  
Yanfang Liu ◽  
Zhengping Jiang ◽  
...  

2020 ◽  
Vol 19 (3) ◽  
pp. 76-82
Author(s):  
V. S. Poletika ◽  
Yu. V. Kolobovnikova ◽  
O. I. Urazova ◽  
O. A. Vasileva ◽  
A. I. Dmitrieva ◽  
...  

2021 ◽  
Vol 35 (4) ◽  
Author(s):  
Xiumei Wei ◽  
Cheng Li ◽  
Yu Zhang ◽  
Kang Li ◽  
Jiaqi Li ◽  
...  

Metabolites ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. 461
Author(s):  
Jenifer Sanchez ◽  
Ian Jackson ◽  
Katie R. Flaherty ◽  
Tamara Muliaditan ◽  
Anna Schurich

Upon activation T cells engage glucose metabolism to fuel the costly effector functions needed for a robust immune response. Consequently, the availability of glucose can impact on T cell function. The glucose concentrations used in conventional culture media and common metabolic assays are often artificially high, representing hyperglycaemic levels rarely present in vivo. We show here that reducing glucose concentration to physiological levels in culture differentially impacted on virus-specific compared to generically activated human CD8 T cell responses. In virus-specific T cells, limiting glucose availability significantly reduced the frequency of effector-cytokine producing T cells, but promoted the upregulation of CD69 and CD103 associated with an increased capacity for tissue retention. In contrast the functionality of generically activated T cells was largely unaffected and these showed reduced differentiation towards a residency phenotype. Furthermore, T cells being cultured at physiological glucose concentrations were more susceptible to viral infection. This setting resulted in significantly improved lentiviral transduction rates of primary cells. Our data suggest that CD8 T cells are exquisitely adapted to their niche and provide a reminder of the need to better mimic physiological conditions to study the complex nature of the human CD8 T cell immune response.


Sign in / Sign up

Export Citation Format

Share Document